Stock IMNM IMMUNOME, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Immunome, Inc.

Equities

IMNM

US45257U1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
14.22 USD -0.84% Intraday chart for Immunome, Inc. +2.82% +32.90%
May. 21 Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing MT
May. 20 Immunome Completes Purchase of Antibodies From Atreca MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing
Immunome Completes Purchase of Antibodies From Atreca
Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc..
Immunome Appoints Max Rosett as CFO
Immunome, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Immunome, Inc. Appoints Kinney Horn as Chief Business Officer
Immunome, Inc. Appoints Sandra M. Swain to Board of Directors
Immunome, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Immunome, Inc. completed the acquisition of Assets from Ayala Pharmaceuticals, Inc..
Immunome Closes $230 Million Public Offering
Sector Update: Health Care Stocks Gain Late Afternoon
Top Midday Gainers
Immunome to Acquire Potential Desmoid Tumor Treatment From Ayala Pharmaceuticals; Shares Climb
Immunome, Inc. Announces Promotion of Max Rosett to Executive Vice President, Operations
Immunome, Inc. and Zentalis Pharmaceuticals, Inc. Enter into an Exclusive, Worldwide License Agreement Under Which Immunome Has Licensed from Zentalis ZPC-21, A Preclinical Ror1 Antibody-Drug Conjugate
Immunome Appoints Phil Roberts as Chief Technical Officer
Immunome Appoints Phil Roberts as Chief Technical Officer
Immunome, Inc. Announces Board Changes
Immunome, Inc. Announces Executive Changes, Effective January 2, 2024
Immunome Signs Asset Purchase Agreement for Acquisition of Antibody-Related Assets From Atreca
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMNM Stock
  4. News Immunome, Inc.
  5. Other languages